Trial · NCT01922258
Adverse events34
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 34
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Somnolence | Nervous system disorders | Brexpiprazole (Flexible Dose Range 0.5 to 2 mg/Day) | 8 | 132 | |
| other | Somnolence | Nervous system disorders | Placebo (Flexible Dose Range 0.5 to 2 mg/Day) | 5 | 137 | |
| other | Dizziness | Nervous system disorders | Brexpiprazole (Flexible Dose Range 0.5 to 2 mg/Day) | 6 | 132 | |
| other | Dizziness | Nervous system disorders | Placebo (Flexible Dose Range 0.5 to 2 mg/Day) | 7 | 137 | |
| other | Headache | Nervous system disorders | Brexpiprazole (Flexible Dose Range 0.5 to 2 mg/Day) | 10 | 132 | |
| other | Headache | Nervous system disorders | Placebo (Flexible Dose Range 0.5 to 2 mg/Day) | 17 | 137 | |
| serious | Gastrointestinal haemorrhage | Gastrointestinal disorders | Brexpiprazole (Flexible Dose Range 0.5 to 2 mg/Day) | 0 | 132 | |
| serious | Gastrointestinal haemorrhage | Gastrointestinal disorders | Placebo (Flexible Dose Range 0.5 to 2 mg/Day) | 1 | 137 | |
| serious | Non-Cardiac Chest Pain | General disorders | Brexpiprazole (Flexible Dose Range 0.5 to 2 mg/Day) | 1 | 132 | |
| serious | Non-Cardiac Chest Pain | General disorders | Placebo (Flexible Dose Range 0.5 to 2 mg/Day) | 0 | 137 | |
| serious | Pneumonia | Infections and infestations | Brexpiprazole (Flexible Dose Range 0.5 to 2 mg/Day) | 1 | 132 | |
| serious | Pneumonia | Infections and infestations | Placebo (Flexible Dose Range 0.5 to 2 mg/Day) | 1 | 137 | |
| serious | Femur Fracture | Injury, poisoning and procedural complications | Brexpiprazole (Flexible Dose Range 0.5 to 2 mg/Day) | 0 | 132 | |
| serious | Femur Fracture | Injury, poisoning and procedural complications | Placebo (Flexible Dose Range 0.5 to 2 mg/Day) | 1 | 137 | |
| serious | Hip Fracture | Injury, poisoning and procedural complications | Brexpiprazole (Flexible Dose Range 0.5 to 2 mg/Day) | 0 | 132 | |
| serious | Hip Fracture | Injury, poisoning and procedural complications | Placebo (Flexible Dose Range 0.5 to 2 mg/Day) | 1 | 137 | |
| serious | Subdural haematoma | Injury, poisoning and procedural complications | Brexpiprazole (Flexible Dose Range 0.5 to 2 mg/Day) | 1 | 132 | |
| serious | Subdural haematoma | Injury, poisoning and procedural complications | Placebo (Flexible Dose Range 0.5 to 2 mg/Day) | 0 | 137 | |
| serious | Dehydration | Metabolism and nutrition disorders | Brexpiprazole (Flexible Dose Range 0.5 to 2 mg/Day) | 0 | 132 | |
| serious | Dehydration | Metabolism and nutrition disorders | Placebo (Flexible Dose Range 0.5 to 2 mg/Day) | 1 | 137 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01922258/events